Longevity Vision Fund is a $100M investment fund dedicated to making longevity affordable and accessible to all. The fund accelerates longevity breakthroughs by investing in companies that develop technologies, products, and services that extend healthy human lifespans and overcome the negative effects of aging
Longevity Vision Fund provides Seed
to Series C funding to biotech and life extension-focused companies that have demonstrated affordable longevity potential and vision of milestones driving up the value of the company and market validation.
Industries: Biopharma
Biotechnology
Genetics
Life Science
Therapeutics
Health Care
Medical Device
Medical
Clinical Trials
Artificial Intelligence
Health Diagnostics
Machine Learning
mHealth
Software
Location: New York City, New York, United States